Influence of Renal Function on the Use of Guideline-Recommended Therapies for Patients With Heart Failure

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1140-1146

  Heywood, J Thomas ^a   Fonarow, Gregg C ^b   Yancy, Clyde W ^c   Albert, Nancy M ^d   Curtis, Anne B ^e   Stough, Wendy Gattis ^f,g   Gheorghiade, Mihai ^h   McBride, Mark L ⁱ   Mehra, Mandeep R ^j   O'Connor, Christopher M ^g   Reynolds, Dwight ^k   Walsh, Mary Norine ^l  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f Campbell University   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ Outcome Sciences Inc   (United States)

^j UNIVERSITY OF MARYLAND   (United States)

^k UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^l Care Group   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

AGED; CARDIOVASCULAR AGENTS; CREATININE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OUTPATIENTS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77950458423     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.016     Document Type: Article

References (24)

1. Fonarow G.C., and Heywood J.T. The confounding issue of comorbid renal insufficiency. Am J Med 119 (2006) S17-S25
2. Liang K.V., Williams A.W., Greene E.L., and Redfield M.M. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36 (2008) S75-S88
3. Saltzman H.E., Sharma K., Mather P.J., Rubin S., Adams S., and Whellan D.J. Renal dysfunction in heart failure patients: what is the evidence?. Heart Fail Rev 12 (2007) 37-47
4. Schiffrin E.L., Lipman M.L., and Mann J.F.E. Chronic kidney disease: effects on the cardiovascular system. Circulation 116 (2007) 85-97
5. Bibbins-Domingo K., Lin F., Vittinghoff E., Barrett-Connor E., Grady D., and Shlipak M.G. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 44 (2004) 1593-1600
6. Ezekowitz J., McAlister F.A., Humphries K.H., Norris C.M., Tonelli M., Ghali W.A., Knudtson M.L., and APPROACH. Investigators. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44 (2004) 1587-1592
7. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., Granger C.B., Michelson E.L., Ostergren J., Cornel J.H., de Zeeuw D., Pocock S., and van Veldhuisen D.J. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
8. Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., Berkowitz R.L., Galvao M., and Horton D.P. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). A.D.H.E.R.E. Scientific Advisory Committee and Investigators. Am Heart J 149 (2005) 209-216
9. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., and Krumholz H.M. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
10. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 12 (2006) 257-262
11. Lahoz C., Mostaza J.M., Mantilla M.T., Taboada M., Tranche S., Lopez-Rodriquez I., Monteiro B., Soler B., Sanchez-Zamorano M.A., and Martin-Jadraque R. Achievement of therapeutic goals and utilization of evidence-based cardiovascular therapies in coronary heart disease patients with chronic kidney disease. Am J Cardiol 101 (2008) 1098-1102
12. Patel U.D., Hernandez A.F., Liang L., Peterson E.D., LaBresh K.A., Yancy C.W., Albert N.M., Ellrodt G., and Fonarow G.C. Quality of care and outcomes among patients with heart failure and chronic kidney disease: a Get With the Guidelines-Heart Failure Program study. Am Heart J 156 (2008) 674-681
13. Berger A.K., Duval S., Manske C., Vazquez G., Barber C., Miller L., and Luepker R.V. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J 153 (2007) 1064-1073
14. Fonarow G.C., Yancy C.W., Albert N.M., Curtis A.B., Gattis Stough W., Gheorghiade M., Heywood J.T., McBride M.L., Mehra M.R., O'Connor C.M., Reynolds D., and Walsh M.N. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 1 (2008) 98-106
15. Fonarow G.C., Yancy C.W., Albert N.M., Curtis A.B., Gattis Stough W., Gheorghiade M., Heywood J.T., Mehra M., O'Connor C.M., Reynolds D., and Walsh M.N. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J 154 (2007) 12-38
16. Spertus J.A., Eagle K.A., Krumholtz H., Mitchell K.R., and Normand S.L. American College of Cardiology/American Heart Association Task Force on Performance Measures. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 45 (2005) 1147-1156
17. Jessup M., Abraham W.T., Casey D.E., Feldman A.M., Francis G.S., Ganiats T.G., Konstam M.A., Mancini D.M., Rahko P.S., Silver M.A., Stevenson L.W., and Yancy C.W. 2009 Focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009) 1977-2016
18. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes III N.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky H.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J., Stevenson L.W., Sweeney M.O., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Buller C.E., Creager M.A., Ettinger S.M., Faxon D.P., Halperin J.L., Tarkington L.G., and Yancy C.W. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51 (2008) e1-e62
19. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., Antman E.M., Smith Jr. S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., and Riegel B. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society of Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 112 (2005) e154-e235
20. Masoudi F.A., Rathore S.S., Wang Y., Havranek E.P., Curtis J.P., Foody J.M., and Krumholz H.M. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 110 (2004) 724-731
21. Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?. J Am Geriatr Soc 50 (2002) 1297-1300
22. Goldenberg I., Vyas A.K., Hall W.J., Moss A.J., Wang H., He H., Zareba W., McNitt S., Andrews M.A., and D.I.T.-I.I. Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
23. Goldenberg I., Moss A.J., McNitt S., Zareba W., Andrews M.L., Hall W.J., Greenberg H., Case R.B., and Multicenter Automatic Defibrillator Implantation Trial-I.I. Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with left ventricular dysfunction. Am J Cardiol 98 (2006) 485-490
24. Coca S.G., Krumholz H.M., Garg A.X., and Parikh C.R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296 (2006) 1377-1384